- Home
- SEATW vs CERT Comparison
SEATW vs CERT Comparison
Compare SEATW & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEATW
- CERT
- Stock Information
- Founded
- SEATW 2001
- CERT 2008
- Country
- SEATW United States
- CERT United States
- Employees
- SEATW 768
- CERT N/A
- Industry
- SEATW Industrial Machinery/Components
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- SEATW Industrials
- CERT Technology
- Exchange
- SEATW Nasdaq
- CERT Nasdaq
- Market Cap
- SEATW N/A
- CERT 2.3B
- IPO Year
- SEATW N/A
- CERT 2020
- Fundamental
- Price
- SEATW $0.18
- CERT $11.01
- Analyst Decision
- SEATW
- CERT Buy
- Analyst Count
- SEATW 0
- CERT 6
- Target Price
- SEATW N/A
- CERT $15.80
- AVG Volume (30 Days)
- SEATW 2.3K
- CERT 1.4M
- Earning Date
- SEATW 03-04-2025
- CERT 02-26-2025
- Dividend Yield
- SEATW N/A
- CERT N/A
- EPS Growth
- SEATW N/A
- CERT N/A
- EPS
- SEATW N/A
- CERT N/A
- Revenue
- SEATW $774,076,000.00
- CERT $385,148,000.00
- Revenue This Year
- SEATW N/A
- CERT $11.44
- Revenue Next Year
- SEATW N/A
- CERT $8.90
- P/E Ratio
- SEATW $15.73
- CERT N/A
- Revenue Growth
- SEATW 13.91
- CERT 8.70
- 52 Week Low
- SEATW $0.13
- CERT $9.41
- 52 Week High
- SEATW $1.59
- CERT $19.29
- Technical
- Relative Strength Index (RSI)
- SEATW 36.04
- CERT 28.81
- Support Level
- SEATW $0.20
- CERT $10.79
- Resistance Level
- SEATW $0.25
- CERT $12.27
- Average True Range (ATR)
- SEATW 0.04
- CERT 0.63
- MACD
- SEATW -0.01
- CERT -0.22
- Stochastic Oscillator
- SEATW 12.00
- CERT 7.48
About SEATW Vivid Seats Inc. Warrant
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.